HIS
MIRM icon

Harvest Investment Services’s Mirum Pharmaceuticals MIRM Stock Holding History

Harvest Investment Services’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,707
Closed -$236K – 325
2024
Q4 		$236K Buy
+5,707
New +$238K 0.06% 239

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harvest Investment Services's MIRM Position: Q1 2025 in Review

Harvest Investment Services sold out of Mirum Pharmaceuticals (MIRM) in Q1 2025, closing a stake of 5,707 shares — an estimated $236K sold.

Harvest Investment Services first reported a position in MIRM in Q4 2024 and held it in 1 quarter. The position peaked at $236K in Q4 2024. 214 funds tracked by Wall St. Rank hold MIRM as of Q1 2025.

  • Harvest Investment Services reported no remaining Mirum Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Harvest Investment Services sold 5,707 Mirum Pharmaceuticals shares in Q1 2025, an estimated $236K.
  • Harvest Investment Services first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Harvest Investment Services's Mirum Pharmaceuticals position peaked at $236K in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2025.

Based on Harvest Investment Services's 13F filing for Q1 2025, filed 15 May 2025.